Asthma

If you have asthma and qualifying burn-pit or fine-particulate service, current law may presume service connection without the old ten-year diagnosis limit. Under 38 USC §§ 1119 and 1120 and the applicable regulation, the exact service location and date still matter, but a veteran is not pushed into the direct lane merely because the asthma diagnosis came more than ten years after separation. In our analysis of 577 asthma cases at the Board of Veterans' Appeals, the presumptive lane grants at 77.1 percent. The direct lane grants at 46.9 percent. The lane you file in matters.

Once the door is open, a second fight begins. Asthma is rated under DC 6602 on a four-tier ladder: 10, 30, 60, and 100 percent. The tiers are driven by two things: your pulmonary function numbers and your medication pattern. Most veterans land at 30 percent because they're on a daily controller inhaler. A smaller group lands at 60 or 100 percent because of monthly ER visits or daily oral steroids. Here's the catch: in our dataset, 115 of 240 denied claims weren't denied for service connection. They were denied because the symptoms didn't clear the 10 percent threshold. The most common way to lose an asthma claim is to win service connection at zero percent.

This page walks through the four-tier rating ladder, how the current PACT Act presumption works, why older ten-year-window explanations are no longer current, why nearly half of denials are about severity rather than service, and what makes a C&P exam help or hurt your case.

TL;DR

• 577 asthma cases in our BVA dataset. Outcomes: 43.7% granted, 41.6% denied, 14.7% remanded.
• DC 6602 has four rating tiers: 10%, 30%, 60%, and 100%. The 30% tier is the modal outcome (45 of 129 rated grants). The 60% tier is the second-most common (42 cases). The 100% tier shows up more often than expected (27 cases) because daily oral steroid use or near-daily inhalation therapy can clear it.
• Presumptive service connection under the PACT Act burn-pit framework grants at 77.1% (105 cases). Direct service connection grants at 46.9% (318 cases). Secondary service connection grants at 31.0% (29 cases). Aggravation grants at 52.6% (19 cases).
• "Severity insufficient" is the top single denial reason at 115 of 240 classified denials, nearly half. The rating ladder is where many claims that should win partial relief get nothing.
• Strong nexus grants at 97.4%. Weak nexus grants at 2.1%. The opinion quality matters more here than the underlying medicine.
• Current law does not impose the former ten-year diagnosis window on the asthma presumption. The veteran still must match the applicable covered-service location and date rules and have current asthma.
• C&P examination inadequacy rate is roughly 36%, below the overall BVA average. Asthma exams tend to be more mechanical than many conditions because the rating ladder is PFT-driven.

DC 6602 and the Rating Ladder Under 38 CFR § 4.97

Asthma is rated under DC 6602 in the respiratory chapter at 38 CFR § 4.97. The ladder is one of the more mechanical in the schedule, with two of the four tiers anchored to pulmonary function testing (PFT) values and the other two anchored to medication patterns.

The four tiers:

• 10%: FEV-1 of 71 to 80 percent predicted, OR FEV-1/FVC of 71 to 80 percent, OR intermittent inhalational or oral bronchodilator therapy.
• 30%: FEV-1 of 56 to 70 percent predicted, OR FEV-1/FVC of 56 to 70 percent, OR daily inhalational or oral bronchodilator therapy, OR inhalational anti-inflammatory medication.
• 60%: FEV-1 of 40 to 55 percent predicted, OR FEV-1/FVC of 40 to 55 percent, OR at least monthly visits to a physician for required care of exacerbations, OR intermittent (at least three per year) courses of systemic (oral or parenteral) corticosteroids.
• 100%: FEV-1 less than 40 percent predicted, OR FEV-1/FVC less than 40 percent, OR more than one attack per week with episodes of respiratory failure, OR requires daily use of systemic (oral or parenteral) high-dose corticosteroids or immuno-suppressive medications.

Two things stand out about this structure. First, the medication path matters as much as the PFT path. A veteran with normal-looking PFTs but daily oral steroid use clears 100 percent on the medication criteria alone. A veteran with intermittent rescue inhaler use lands at 10 percent regardless of how the PFTs read. Second, the 30 percent tier is unusually broad. "Daily inhalational or oral bronchodilator therapy" or "inhalational anti-inflammatory medication" captures any veteran on a daily controller inhaler, which is the standard of care for moderate persistent asthma. That's why 30 percent is the modal rating.

The 60-to-100 jump is where the structural cliff lives. The 60 percent tier requires monthly physician visits for exacerbations or three or more courses of systemic steroids per year. The 100 percent tier requires daily systemic steroids. Many veterans with severe asthma sit between those thresholds (multiple ER visits per year but not quite monthly, oral steroid use that's frequent but not daily) and end up rated at 60 percent when the clinical picture might support more.

The PACT Act Presumption Changes Almost Everything

Current law provides two related but distinct asthma-presumption lanes. Under 38 USC §§ 1119 and 1120, the listed disease is asthma diagnosed after covered service. Section 1119 defines two covered-service groups: service on or after August 2, 1990 in Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia, or the United Arab Emirates; and service on or after September 11, 2001 in Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, Uzbekistan, or another country later designated by the Secretary. Both statutory groups include airspace above the listed countries.

The separate fine-particulate rule at 38 CFR § 3.320 covers asthma that becomes manifest to any degree at any time following separation from a qualifying period of service. Its service list is narrower: the Southwest Asia theater during the Persian Gulf War, including its airspace, or Afghanistan, Syria, Djibouti, or Uzbekistan on or after September 19, 2001. VA's PACT Act benefits guidance is the official starting point for covered-location and eligibility questions.

Older material may still describe a ten-year diagnosis window. That is not the current restriction. A later diagnosis does not, by itself, force the claim into direct service connection. The veteran still must establish current asthma and service that matches the location and date requirements of the applicable presumption, and VA may consider the rule's stated exceptions.

In our dataset, the presumptive lane grants at 77.1 percent. That's an extraordinary rate, well above almost every other connection type we track. The reason isn't that asthma is clinically easier. It's that the presumption removes the question of whether service caused the condition. The remaining fight is just about the diagnosis and the rating.

For veterans with qualifying service, filing the asthma claim under the PACT Act presumption is structurally the highest-yield move available. The direct-lane grant rate of 46.9 percent is still respectable, but it leaves 30 percentage points of grant probability on the table.

Severity-Insufficient: Why Half the Denials Have Nothing to Do With Service Connection

This is the part of the asthma rating landscape that catches most veterans off guard.

Of 240 denied cases in our BVA dataset, 115 were denied for "severity insufficient." That's 48 percent of denials. The Board grants service connection, agrees the asthma exists, and then declines to assign even the 10 percent rating because the symptoms don't clear the rating ladder's lowest tier.

The pattern that drives "severity insufficient" denials at 10 percent is consistent. The veteran has an asthma diagnosis, but the C&P examination finds normal PFTs and no documented bronchodilator use. The veteran might use a rescue inhaler occasionally during exacerbations, but the medical record doesn't establish "intermittent inhalational or oral bronchodilator therapy" as a sustained pattern.

The 10 percent tier turns on the medication path more than the PFT path. A veteran with FEV-1 in the normal range and no documented inhaler use is at 0 percent, even with a diagnosed condition. A veteran with the same PFTs but a documented prescription for albuterol and a clinical note describing regular use is at 10 percent.

The lesson from this pattern is that the documentation matters at the lowest tier as much as it does at the higher tiers. Veterans who get the asthma diagnosis but don't have it actively managed in the medical record often end up service-connected at 0 percent, which is functionally the same as a denial for compensation purposes.

Nexus Quality and the Cliff Between Strong and Weak

For veterans on the direct lane (the 318 cases in our dataset where presumption didn't apply), the nexus opinion is the case.

Nexus quality breakdown:

• Strong nexus: 76 cases, 97.4% grant rate
• Adequate nexus: 179 cases, 62.6% grant rate
• Weak nexus: 47 cases, 2.1% grant rate
• Missing nexus: 29 cases, 3.4% grant rate
• Not applicable: 246 cases, 26.0% grant rate (mostly presumptive-lane cases where nexus analysis didn't drive the outcome)

The strong-to-weak gap is roughly 95 percentage points. That's the largest single-variable spread in the asthma dataset. The Board's reading of the medical opinion is almost dispositive when it's well-developed and almost dispositive in the other direction when it isn't.

What makes a strong asthma nexus opinion versus a weak one usually comes down to engagement with the in-service exposure history. The strong opinions describe specific exposures (burn pits, JP-8 fuel, sand, mold, post-9/11 dust), connect those exposures to the medical literature on chemical-induced or irritant-induced asthma, address competing post-service causes (smoking, occupational exposures), and explain the time course of symptom development. The weak opinions assert a conclusion without supporting reasoning, often using boilerplate language.

For veterans on the direct lane, the nexus letter is what separates a likely grant from a likely denial. The C&P examiner's opinion is the foundation, but the private nexus letter often does the analytical work the VA examiner skipped.

When Asthma Comes With Other Respiratory Conditions

Asthma frequently appears alongside other respiratory diagnoses, particularly chronic bronchitis, allergic rhinitis, sinusitis, and (less commonly) COPD. The rating math when multiple conditions are service-connected has a specific quirk worth knowing.

Conditions rated under DC 6600 through DC 6817 (most of the respiratory chapter) cannot be combined under the standard combined ratings formula at 38 CFR § 4.25. Instead, when a veteran has multiple respiratory conditions, the Board generally applies the single predominant rating rather than combining. The exception is when the conditions have distinct functional impairment that doesn't overlap.

For veterans with asthma plus chronic bronchitis plus sinusitis, the most useful framing is that each condition should be evaluated for whether it produces functional impairment beyond what the predominant condition explains. If the answer is yes, separate ratings may apply. If the answer is no, the single highest tier across the respiratory cluster controls.

This is one of the more contested areas of respiratory rating analysis at the Board, and the outcomes vary based on how the medical opinion describes the functional contributions of each condition.

What the Board Looks For in Asthma Grants

A few patterns we see in granted asthma cases:

Documented in-service onset or exacerbation. The strongest direct cases have service treatment records showing respiratory complaints, prescriptions for bronchodilators, or in-service pulmonary function testing. Veterans who can document the asthma began or worsened during service generally have a more straightforward path.

Continuity of treatment post-service. Treatment records showing regular pulmonology follow-up, controller medications, and rescue inhaler use establish that the condition has been chronic and active. The Board reads "controlled on inhaler" as evidence the condition is real and persistent.

PFTs that capture impairment. A pulmonary function test in the appeals window documenting reduced FEV-1 or FEV-1/FVC values pushes the rating ladder. PFTs taken during well-controlled periods may show normal values; the rating analysis benefits from testing during exacerbations when possible.

Engagement with the PACT Act framework when applicable. For veterans with qualifying service, identify the lane that actually applies: 38 USC §§ 1119 and 1120, 38 CFR § 3.320, or both. The broader statutory service list does not automatically establish eligibility under the narrower § 3.320 service rule.

Filing PACT Act vs. Filing Direct: Don't File the Wrong Way

Asthma has a presumptive lane and a direct-service-connection lane, and the presumptive lane itself has two authorities. If you have asthma diagnosed after service covered by § 1119, raise the statutory presumption under 38 USC §§ 1119 and 1120. If asthma became manifest after qualifying service under § 3.320's narrower location and date rules, raise the fine-particulate presumption under 38 CFR § 3.320. Raise both only when the facts meet both authorities.

If your service falls outside the covered location or date rules, you can still argue direct service connection. That means your evidence has to do more work: in-service exposure history, medical literature, continuity of symptoms, and a clinician who can explain why your asthma is tied to service. A diagnosis more than ten years after separation is not, standing alone, a reason to put a qualifying veteran in this direct-only lane.

The practical move is to sort the lane before you file. If you are not sure which bucket you fall into, use the asthma evidence checklist and compare your service dates, deployment locations, diagnosis date, and medical records before submitting.

What to Bring to Your Asthma C&P Exam

Asthma C&P exams are mechanical, but that does not mean they are automatic. Bring a current medication list with prescription dates, pharmacy refill history, pulmonary function tests, ER or urgent-care visits, and a short log of exacerbations.

The examiner needs to see the medication pattern, not just hear that you have asthma. A daily controller inhaler matters differently than occasional rescue inhaler use. Oral steroid courses matter differently than inhaled medication. If you have been tracking attacks, triggers, and rescue inhaler use, bring that pattern into the exam; the symptom tracker is built for exactly that kind of record.

If you are nervous about what the examiner may ask, review the respiratory C&P exam prep checklist before the appointment so you can describe frequency, triggers, medication use, and flare-ups without guessing.

How to Document the 10 Percent Tier

A diagnosis alone can still leave you at zero percent. The 10 percent tier usually turns on documented bronchodilator therapy or qualifying PFT numbers. If the record shows "asthma" but does not show a prescription pattern, refill history, or treating note describing use, the Board may treat the condition as noncompensable.

The strongest low-tier evidence is boring but persuasive: albuterol or controller inhaler prescriptions, pharmacy refill records, notes from a treating pulmonologist or primary-care clinician, and a clear statement that the medication is used for asthma. A buddy statement about in-service breathing complaints can support onset, but the rating tier still needs medical documentation.

The 60-to-100 Percent Cliff

The jump from 60 to 100 percent is steep. Monthly physician visits for exacerbations, three or more systemic steroid courses per year, daily systemic high-dose corticosteroids, or episodes of respiratory failure are the kinds of evidence that move the rating above the ordinary controller-inhaler tier.

Veterans often describe this as "severe asthma," but the rating schedule wants a specific paper trail. If you are arguing for 60 or 100 percent, collect dates: ER visits, urgent-care visits, steroid bursts, pulmonology visits, respiratory failure episodes, and medication changes. The details matter more than the label.

Common Asthma Secondaries Veterans Miss

Asthma rarely travels alone. Sinusitis often co-occurs with asthma, sleep apnea is a frequent respiratory secondary theory, GERD can worsen nighttime symptoms, and anxiety or adjustment symptoms can follow a chronic breathing condition.

Secondary conditions do not replace the asthma rating. They stack separately when the evidence supports them. If you think asthma has caused or aggravated another condition, map the theory before filing with the secondary condition pathways tool. For other respiratory claims, COPD shares respiratory-chapter rating quirks, but the diagnostic and nexus paths are different enough that it should be evaluated separately.

Bottom Line

Asthma is rated under 38 CFR § 4.97 DC 6602 at four tiers (10, 30, 60, and 100 percent) anchored to FEV-1 values, medication frequency, and exacerbation patterns. The current burn-pit and fine-particulate presumptions do not impose the former ten-year diagnosis window; exact service locations, dates, and the applicable authority still matter. In our BVA dataset, presumptive service connection grants at 77 percent versus 47 percent for direct, the largest connection-type spread in the asthma data. The biggest pattern denying asthma grants at the lowest tier isn't service connection. It's severity-insufficient findings under DC 6602's 10 percent threshold, which requires documented bronchodilator use, not just a diagnosis. For veterans on the direct lane, strong nexus opinions grant at 97 percent versus 2 percent for weak nexus, the steepest opinion-quality cliff in the respiratory cluster. The structural high-yield move for any veteran with qualifying PACT Act service is filing under the presumption rather than the direct lane, even when both paths are available.

Related Conditions

Asthma claim strategy often overlaps with sinusitis, sleep apnea, and COPD. You can compare the full condition library from the VA disability conditions index.

Methodology and Limitations

• Data source: 38 CFR § 4.97 DC 6602, 38 CFR § 3.320, 38 USC §§ 1119 and 1120, and Claim Raven's analysis of BVA decisions tagged with asthma as the primary condition.
• Sample size: 577 BVA decisions involving asthma as the primary condition. Outcomes split granted 43.7% (252), denied 41.6% (240), remanded 14.7% (85). Connection-type, nexus-quality, denial-reason, and rating-tier breakdowns are coded from the Board's discussion in each decision.
• Limitations: The dataset captures BVA-level decisions and is not representative of all asthma claims filed with VA. Many asthma claims grant at the regional office and never appear in BVA data. The PACT Act presumption has been amended since enactment; current regulatory text controls over older interpretations in our older case set. Rating-tier distribution is based on the cases where a tier was specifically discussed in the Board's decision. C&P examination inadequacy rates are based on the Board's express findings of inadequacy. These observations describe BVA patterns and are not predictions of individual outcomes, and Claim Raven is data analysis, not legal, medical, or VA-accredited advice.